Heterosexually active men, masculinities, HIV prevention, and the search for post-exposure prophylaxis following sexual exposure

Carregando...
Imagem de Miniatura
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
UNIVERSIDAD NACIONAL DE LANUS
Citação
SALUD COLECTIVA, v.15, article ID UNSP e2144, 14p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Hegemonic masculinity has distanced heterosexually active men from the responses to the HIV epidemic. However, with the combined prevention paradigm, post-exposure prophylaxis offers new ways to manage the risks of HIV infection, while at the same time bringing about new challenges. The aim of this paper is to discuss - through the lens of gender and masculinities - how heterosexually active men perceive their HIV risk and how they manage prevention methods and strategies, including post-exposure prophylaxis. Employing qualitative methods, 16 heterosexually active men in five health services from different Brazilian cities were interviewed. The analysis indicates that condom use - the main prevention method - was conditioned by subjective and contextual factors, and its failure stands out as the primary reason for seeking out post-exposure prophylaxis. We argue that ideals of hegemonic masculinity permeate perceptions and risk management discourses in the current context of the HIV/AIDS epidemic.
Palavras-chave
Masculinity, Heterosexuality, Men's Health, Disease Prevention, HIV, Post-Exposure Prophylaxis, Brazil
Referências
  1. Cardoso LRD, 2008, ARCH CLIN PSYCHIA S1, V35, pS70
  2. Connell R, 2015, GENERO PERSPECTIVA G
  3. Connell R, 2005, MASCULINITIES
  4. Costa EC V, 2017, REV ESTUDIOS INVESTI, P206
  5. Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1
  6. Couto MT, 2018, CURR SOCIOL, V66, P704, DOI 10.1177/0011392117735360
  7. Dennison O, 2014, J AM COLL HEALTH, V62, P309, DOI 10.1080/07448481.2014.899232
  8. Dourado I, 2015, REV BRASILEIRA EP S1, V18, pS63
  9. Dworkin SL, 2015, MEN RISK MASCULINITY
  10. Fernandez-Balbuena S, 2013, HIV MED, V14, P252, DOI 10.1111/j.1468-1293.2012.01056.x
  11. Rebello LEFD, 2011, INTERFACE-BOTUCATU, V15, P67, DOI 10.1590/S1414-32832010005000045
  12. Fleming PJ, 2016, AIDS BEHAV, V20, P788, DOI 10.1007/s10461-015-1264-y
  13. Garcia S, 2010, SAUDE SOC-SAO PAULO, V19, P9, DOI 10.1590/S0104-12902010000600003
  14. Gender Connell R., 2012, SOC SCI MED, V74, P1675, DOI 10.1016/J.SOCSCIMED.2011.06.006.13
  15. Gomes R., 2008, SEXUALIDADE MASCULIN
  16. Gomes R, 2005, AVALIACAO TRIANGULAC
  17. Gomes Romeu, 2011, Physis, V21, P113, DOI 10.1590/S0103-73312011000100007
  18. Gomes Vera Lúcia de Oliveira, 2011, Esc. Anna Nery, V15, P22, DOI 10.1590/S1414-81452011000100004
  19. Grangeiro A, 2015, REV BRASILEIRA EP S1, V18, pS1
  20. Grangeiro A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009021
  21. Guerriero Iara, 2002, Rev. Saúde Pública, V36, P50, DOI 10.1590/S0034-89102002000500008
  22. Higgins JA, 2010, AM J PUBLIC HEALTH, V100, P435, DOI 10.2105/AJPH.2009.159723
  23. Hill BJ, 2015, SEX HEALTH, V12, P397, DOI 10.1071/SH14051
  24. Kanda L, 2018, AFR J PRIM HEALTH CA, V10, DOI 10.4102/phcfm.v10i1.1492
  25. Leal AF, 2015, REV BRASILEIRA EP S1, V18, pS143
  26. Maksud I, 2015, REV BRASILEIRA EP S1, V18, pS104
  27. McElrath K, 2017, J RACIAL ETHN HEALTH, V4, P112, DOI 10.1007/s40615-016-0208-1
  28. Mehta SA, 2011, SEX TRANSM INFECT, V87, P344, DOI 10.1136/sti.2010.046284
  29. Minayo MCDS, 2011, PESQUISA SOCIAL TEOR
  30. Ministerio da Saude, 2017, PROT CLIN DIR TER HE
  31. Ministerio da Saude, 2018, B EP HEP VIR
  32. Ministerio da Saude, 2017, PREV COMB HIV BAS CO
  33. Otten RA, 2000, J VIROL, V74, P9771, DOI 10.1128/JVI.74.20.9771-9775.2000
  34. Perrusi A, 2012, REV CIENCIAS SOCIAIS, V2, P179
  35. Ricouer P., 2012, TEMPO E NARRATIVA, VIII
  36. Rotheram-Borus MJ, 2009, ANNU REV CLIN PSYCHO, V5, P143, DOI 10.1146/annurev.clinpsy.032408.153530
  37. Silva CGM, 2002, REV SAUDE PUBLICA S4, V36, pS40
  38. Stephenson R, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0939-1
  39. Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45
  40. TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197
  41. UNAIDS, 2017, GUIA TERM UNAIDS
  42. UNAIDS, 2010, COMB HUV PREV TAIL C
  43. Walters SM, 2017, JAIDS-J ACQ IMM DEF, V75, pS383, DOI 10.1097/qai.0000000000001415